Immunohistochemistry Applied to the Differential Diagnosis Between Ductal and Lobular Carcinoma of the Breast

Carregando...
Imagem de Miniatura
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2013
Editora
LIPPINCOTT WILLIAMS & WILKINS
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
MOURA, Rafael de Deus
WLUDARSKI, Sheila C. L.
BACCHI, Carlos E.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, v.21, n.1, p.1-12, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The distinction between classic lobular and ductal carcinoma, both in situ and invasive, has important therapeutic and management implications. Most ductal and lobular carcinomas are distinguished readily on hematoxylin-eosin-stained sections because of distinct histomorphologic features. In cases with ambiguous morphologic features, however, categorization in one or another type can be a challenge. Several immunohistochemical markers, including epithelial cadherin, p120, beta-catenin, and low-molecular-weight and high-molecular-weight cytokeratins among others, have been introduced to help better discriminate between lobular neoplasia and ductal carcinoma. In this critical review of the literature, we comment about the usefulness and the limitations of these markers to improve the accuracy in the differential diagnosis of breast pathology.
Palavras-chave
breast, ductal carcinoma, lobular carcinoma, E-cadherin, p120
Referências
  1. Abdel-Fatah TMA, 2007, AM J SURG PATHOL, V31, P417, DOI 10.1097/01.pas.0000213368.41251.b9
  2. Abdel-Fatah TMA, 2008, AM J SURG PATHOL, V32, P513, DOI 10.1097/PAS.0b013e318161d1a5
  3. Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004
  4. Acs G, 2001, AM J CLIN PATHOL, V115, P85
  5. Arpino G, 2004, BREAST CANCER RES, V6, pR149, DOI 10.1186/bcr767
  6. Asgeirsson KS, 2000, EUR J CANCER, V36, P1098, DOI 10.1016/S0959-8049(00)00062-9
  7. Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034
  8. Bedrosian I, 2003, CANCER, V98, P468, DOI 10.1002/cncr.11490
  9. BERNSTEIN JL, 1992, AM J EPIDEMIOL, V136, P925
  10. Berx G, 1996, ONCOGENE, V13, P1919
  11. Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985
  12. Brandt S, 2008, MODERN PATHOL, V21, p24A
  13. Bratthauer GL, 2002, HUM PATHOL, V33, P620, DOI 10.1053/hupa.2002.124789
  14. BROET P, 1995, J CLIN ONCOL, V13, P1578
  15. Chan JKC, 2001, ADV ANAT PATHOL, V8, P165, DOI 10.1097/00125480-200105000-00005
  16. Chen CL, 2002, JAMA-J AM MED ASSOC, V287, P734, DOI 10.1001/jama.287.6.734
  17. Chivukula M, 2008, AM J SURG PATHOL, V32, P1721, DOI 10.1097/PAS.0b013e31817dc3a6
  18. Cleton-Jansen AM, 2002, BREAST CANCER RES, V4, P5, DOI 10.1186/bcr416
  19. Cowin P, 1996, CURR OPIN CELL BIOL, V8, P56, DOI 10.1016/S0955-0674(96)80049-4
  20. Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014
  21. Dabbs DJ, 2007, APPL IMMUNOHISTO M M, V15, P260, DOI 10.1097/01.pai.0000213128.78665.3c
  22. Dabbs DJ, 2007, AM J SURG PATHOL, V31, P427, DOI 10.1097/01.pas.0000213386.63160.3f
  23. Da Silva L, 2008, AM J SURG PATHOL, V32, P773, DOI 10.1097/PAS.0b013e318158d6c5
  24. DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9
  25. DICOSTANZO D, 1990, AM J SURG PATHOL, V14, P12, DOI 10.1097/00000478-199001000-00002
  26. DOMAGALA W, 1993, VIRCHOWS ARCH A, V423, P497, DOI 10.1007/BF01606541
  27. Droufakou S, 2001, INT J CANCER, V92, P404, DOI 10.1002/ijc.1208
  28. DUTOIT RS, 1989, BRIT J CANCER, V60, P605, DOI 10.1038/bjc.1989.323
  29. ELLIS IO, 1992, HISTOPATHOLOGY, V20, P479
  30. Ellis IO, 2003, TUMORS BREAST FEMALE, P23
  31. Esposito NN, 2007, MODERN PATHOL, V20, P130, DOI 10.1038/modpathol.3800721
  32. EUSEBI V, 1992, HUM PATHOL, V23, P655, DOI 10.1016/0046-8177(92)90321-S
  33. Fadare O, 2006, AM J SURG PATHOL, V30, P1445, DOI 10.1097/01.pas.0000213290.58283.82
  34. FISHER ER, 1977, HUM PATHOL, V8, P679, DOI 10.1016/S0046-8177(77)80096-8
  35. Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205
  36. Goldstein NS, 2001, CANCER, V92, P738, DOI 10.1002/1097-0142(20010815)92:4<738::AID-CNCR1377>3.0.CO;2-Z
  37. Goldstein NS, 2002, AM J CLIN PATHOL, V118, P425, DOI 10.1309/JMRD-W08Y-6K8M-7AD8
  38. Goldstein NS, 2001, AM J CLIN PATHOL, V115, P534
  39. GRAFF JR, 1995, CANCER RES, V55, P5195
  40. Gruel N, 2010, EUR J CANCER, V46, P2399, DOI 10.1016/j.ejca.2010.05.013
  41. Gwin K, 2010, APPL IMMUNOHISTO M M, V18, P526, DOI 10.1097/PAI.0b013e3181e8d54b
  42. Hajra KM, 2002, CANCER RES, V62, P1613
  43. Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790
  44. Harigopal Malini, 2005, World J Surg Oncol, V3, P73, DOI 10.1186/1477-7819-3-73
  45. HARRIS M, 1984, BRIT J CANCER, V50, P23, DOI 10.1038/bjc.1984.135
  46. HORN PL, 1988, AM J EPIDEMIOL, V128, P309
  47. JAIN SJ, 1993, EUR J CANCER, V29A, P2155, DOI 10.1016/0959-8049(93)90053-I
  48. Katz A, 2007, LANCET ONCOL, V8, P55, DOI 10.1016/S1470-2045(06)71011-7
  49. Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125
  50. Kollias J, 1999, EUR J SURG ONCOL, V25, P584, DOI 10.1053/ejso.1999.0711
  51. Korkola JE, 2003, CANCER RES, V63, P7167
  52. Lehr HA, 2000, AM J CLIN PATHOL, V114, P190
  53. LESSER ML, 1982, SURGERY, V91, P234
  54. Li CI, 2003, JAMA-J AM MED ASSOC, V289, P1421, DOI 10.1001/jama.289.11.1421
  55. Li CI, 2006, CANCER EPIDEM BIOMAR, V15, P946, DOI 10.1158/1055-9965.EPI-05-0881
  56. MARTINEZ V, 1979, HISTOPATHOLOGY, V3, P467, DOI 10.1111/j.1365-2559.1979.tb03029.x
  57. Mastracci TL, 2005, MODERN PATHOL, V18, P741, DOI 10.1038/modpathol.3800362
  58. Mathieu MC, 2004, EUR J CANCER, V40, P342, DOI 10.1016/j.ejca.2003.08.015
  59. MAZOUJIAN G, 1989, CANCER, V63, P2156, DOI 10.1002/1097-0142(19890601)63:11<2156::AID-CNCR2820631115>3.0.CO;2-B
  60. Middleton LP, 2000, AM J SURG PATHOL, V24, P1650, DOI 10.1097/00000478-200012000-00009
  61. Moinfar F, 1999, AM J SURG PATHOL, V23, P1048, DOI 10.1097/00000478-199909000-00007
  62. MOLL R, 1993, AM J PATHOL, V143, P1731
  63. Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841
  64. Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291
  65. NEWMAN W, 1966, ANN SURG, V164, P305, DOI 10.1097/00000658-196608000-00018
  66. Otterbach F, 2000, HISTOPATHOLOGY, V37, P232, DOI 10.1046/j.1365-2559.2000.00882.x
  67. Oyama T, 1998, CANCER RES, V58, P2876
  68. Qureshi HS, 2006, AM J CLIN PATHOL, V125, P377, DOI 10.1309/WMX7DRWTFVQP2LOT
  69. Radhi JM, 2000, HISTOPATHOLOGY, V36, P156
  70. Rakha EA, 2010, AM J SURG PATHOL, V34, P1472, DOI 10.1097/PAS.0b013e3181f01916
  71. Rakha EA, 2010, SEMIN DIAGN PATHOL, V27, P49, DOI 10.1053/j.semdp.2009.12.009
  72. Rakha EA, 2009, BREAST CANCER RES TR, V114, P243, DOI 10.1007/s10549-008-0007-4
  73. Rakha EA, 2008, EUR J CANCER, V44, P73, DOI 10.1016/j.ejca.2007.10.009
  74. Rakha EA, 2008, BREAST CANCER RES TR, V111, P121, DOI 10.1007/s10549-007-9768-4
  75. Reis-Filho Jorge S., 2002, Cancer, V94, P2114, DOI 10.1002/cncr.0681
  76. Reis-Filho JS, 2002, CANCER, V94, P2115
  77. Rozan S, 1998, INT J CANCER, V79, P27, DOI 10.1002/(SICI)1097-0215(19980220)79:1<27::AID-IJC6>3.0.CO;2-Y
  78. Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439
  79. SastreGarau X, 1996, CANCER, V77, P113, DOI 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8
  80. Schelfout K, 2004, EUR RADIOL, V14, P1209, DOI 10.1007/s00330-004-2275-7
  81. Schnitt S. J., 2009, BIOPSY INTERPRETATIO
  82. SHIMOYAMA Y, 1992, CANCER RES, V52, P5770
  83. SILVERSTEIN MJ, 1994, CANCER, V73, P1673, DOI 10.1002/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B
  84. Sneige N, 2002, MODERN PATHOL, V15, P1044, DOI 10.1097/01.MP.0000030450.20581.E3
  85. SOOMRO S, 1991, J CLIN PATHOL, V44, P211, DOI 10.1136/jcp.44.3.211
  86. Strathdee G, 2002, SEMIN CANCER BIOL, V12, P373, DOI 10.1016/S1044-579X(02)00057-3
  87. Sullivan PS, 2009, BREAST J, V15, P146, DOI 10.1111/j.1524-4741.2009.00689.x
  88. Suryadevara A, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-51
  89. Tavassoli FA, 2009, TUMORS MAMMARY GLAND
  90. Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55
  91. Viale G, 2009, BREAST CANCER RES TR, V117, P211, DOI 10.1007/s10549-008-0112-4
  92. Vos CBJ, 1997, BRIT J CANCER, V76, P1131, DOI 10.1038/bjc.1997.523
  93. Wahed Amer, 2002, Ann Diagn Pathol, V6, P349, DOI 10.1053/adpa.2002.36660
  94. WEIDNER N, 1992, HUM PATHOL, V23, P1167, DOI 10.1016/0046-8177(92)90035-2
  95. Weigelt B, 2010, J PATHOL, V220, P45, DOI 10.1002/path.2629
  96. Wheeler DT, 2004, AM J SURG PATHOL, V28, P1587, DOI 10.1097/00000478-200412000-00006
  97. YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416
  98. Zafrani B, 2000, HISTOPATHOLOGY, V37, P536, DOI 10.1046/j.1365-2559.2000.01006.x